Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2014-03-31
2016-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Myofascial Release and Muscle Activity
NCT04808024
Myofascial Pain and Central Sensitization
NCT04929171
Dry Needling in Subjects With Delayed Onset Muscle Soreness
NCT03876080
Neuroplastic Mechanisms Underlying Augmented Neuromuscular Training
NCT04069520
Comparison of Dry Needle and Massotherapy on Tolerance Effort and Soreness
NCT03619928
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Methodology: Reliability (Test re-test study and validity (cross sectional study) of a short form of MMT 8 and a questionnaire to assess difficulties in activities of daily life (MAP) in myositis patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Non intervention study
Test - Retest of measurements
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age over 18
* Sufficiently understanding of German language
* able to understand and follow verbal and written instructions
* signed informed consent to participate in the study
* Age over 18
* Sufficiently understanding of German language
* able to understand and follow verbal and written instructions
* signed informed consent to participate in the study
Exclusion Criteria
* Pulmonary hypertension
* Osteoporosis
* Severe cardiovascular and/or pulmonary disease
* Pain syndrome
* Paresis
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Baschung Pfister Pierrette, MPH
Role: STUDY_CHAIR
University of Zurich
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Zurich
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014-0022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.